Catalyst Wire Dossier Catalyst Wire Dossier

Mogamulizumab (Poteligeo)

mogamulizumab · Kyowa Kirin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mogamulizumab (Poteligeo), covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) [EARLY_Phase 1]

See pricing